DIGICAP consortium digitalizes medical device conformity assessments
Analysis based on 6 articles · First reported Sep 03, 2026 · Last updated Sep 03, 2026
The initiative could streamline regulatory approval for medical devices in Europe, potentially benefiting manufacturers and technology providers by reducing time-to-market. DistillerSR's involvement may enhance its reputation and market position in the regulatory technology space, though the financial impact is likely modest in the near term.
DistillerSR, a provider of AI-enabled literature review automation, announced its participation in the DIGICAP project, a €4 million European initiative funded under Horizon Europe. The project unites 19 organizations across 12 EU countries to digitalize the conformity assessment process for medical devices and in vitro diagnostics under the EU Medical Device Regulation and In Vitro Diagnostic Regulation. DistillerSR is one of five regulatory technology providers selected, alongside Veeva, MEDDEVO, Aurevia, and Hardian Health. The consortium is led by TEAM-NB and includes MedTech Europe. The project aims to replace document-based exchanges with machine-readable submissions, consensus APIs, and automated validation, potentially reducing certification times from up to 24 months. DistillerSR will contribute to co-designing the digitalization framework, providing feasibility study input, and participating in pilot testing. The project kicks off in September 2026 in Malaga, Spain, and will run for three years.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard